650 related articles for article (PubMed ID: 27574175)
1. Metastatic disease from uveal melanoma: treatment options and future prospects.
Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
[TBL] [Abstract][Full Text] [Related]
2. Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives.
Comito F; Marchese PV; Ricci AD; Tober N; Peterle C; Sperandi F; Melotti B
Future Oncol; 2021 Nov; 17(33):4583-4606. PubMed ID: 34431316
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel chemotherapeutic strategies for metastatic uveal melanoma.
Fagone P; Caltabiano R; Russo A; Lupo G; Anfuso CD; Basile MS; Longo A; Nicoletti F; De Pasquale R; Libra M; Reibaldi M
Sci Rep; 2017 Mar; 7():44564. PubMed ID: 28303962
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma.
Spagnolo F; Caltabiano G; Queirolo P
Cancer Treat Rev; 2012 Aug; 38(5):549-53. PubMed ID: 22270078
[TBL] [Abstract][Full Text] [Related]
5. Metastatic uveal melanoma: biology and emerging treatments.
Woodman SE
Cancer J; 2012; 18(2):148-52. PubMed ID: 22453016
[TBL] [Abstract][Full Text] [Related]
6. The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019).
Chua V; Mattei J; Han A; Johnston L; LiPira K; Selig SM; Carvajal RD; Aplin AE; Patel SP
Clin Cancer Res; 2021 Jan; 27(1):28-33. PubMed ID: 33060121
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma.
Chua V; Lapadula D; Randolph C; Benovic JL; Wedegaertner PB; Aplin AE
Mol Cancer Res; 2017 May; 15(5):501-506. PubMed ID: 28223438
[TBL] [Abstract][Full Text] [Related]
8. Response to Anti-PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis.
Johnson DB; Bao R; Ancell KK; Daniels AB; Wallace D; Sosman JA; Luke JJ
J Natl Compr Canc Netw; 2019 Feb; 17(2):114-117. PubMed ID: 30787124
[No Abstract] [Full Text] [Related]
9. Therapeutic implications of the emerging molecular biology of uveal melanoma.
Patel M; Smyth E; Chapman PB; Wolchok JD; Schwartz GK; Abramson DH; Carvajal RD
Clin Cancer Res; 2011 Apr; 17(8):2087-100. PubMed ID: 21444680
[TBL] [Abstract][Full Text] [Related]
10. Uveal melanoma: physiopathology and new in situ-specific therapies.
Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma: natural history and treatment options for metastatic disease.
Wöll E; Bedikian A; Legha SS
Melanoma Res; 1999 Dec; 9(6):575-81. PubMed ID: 10661768
[TBL] [Abstract][Full Text] [Related]
12. Novel Approaches to the Systemic Management of Uveal Melanoma.
Khan S; Carvajal RD
Curr Oncol Rep; 2020 Jul; 22(10):104. PubMed ID: 32725406
[TBL] [Abstract][Full Text] [Related]
13. Treatment of metastatic uveal melanoma: review and recommendations.
Albert DM; Niffenegger AS; Willson JK
Surv Ophthalmol; 1992; 36(6):429-38. PubMed ID: 1589858
[TBL] [Abstract][Full Text] [Related]
14. Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma.
Karg MM; John L; Refaian N; Buettner C; Rottmar T; Sommer J; Bock B; Resheq YJ; Ksander BR; Heindl LM; Mackensen A; Bosch JJ
Mol Cancer Res; 2022 Aug; 20(8):1320-1336. PubMed ID: 35503453
[TBL] [Abstract][Full Text] [Related]
15. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of metastatic malignant uveal melanoma].
Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma: From diagnosis to treatment and the science in between.
Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
[TBL] [Abstract][Full Text] [Related]
18. Treatment of liver metastases from uveal melanoma.
Rivoire M; Kodjikian L; Baldo S; Kaemmerlen P; Négrier S; Grange JD
Ann Surg Oncol; 2005 Jun; 12(6):422-8. PubMed ID: 15886904
[TBL] [Abstract][Full Text] [Related]
19. Biology of advanced uveal melanoma and next steps for clinical therapeutics.
Luke JJ; Triozzi PL; McKenna KC; Van Meir EG; Gershenwald JE; Bastian BC; Gutkind JS; Bowcock AM; Streicher HZ; Patel PM; Sato T; Sossman JA; Sznol M; Welch J; Thurin M; Selig S; Flaherty KT; Carvajal RD
Pigment Cell Melanoma Res; 2015 Mar; 28(2):135-47. PubMed ID: 25113308
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy for uveal melanoma.
Triozzi PL; Eng C; Singh AD
Cancer Treat Rev; 2008 May; 34(3):247-58. PubMed ID: 18226859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]